| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | U9JLP7V031 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Interleukin-13 inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Asthma | 3 | D001249 | ClinicalTrials |
| Dermatitis, Atopic | 3 | D003876 | ClinicalTrials |
| Pulmonary Disease, Chronic Obstructive | 2 | D029424 | ClinicalTrials |
| Idiopathic Pulmonary Fibrosis | 2 | D054990 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 953400-68-5 |
| ChEMBL | CHEMBL1743035 |
| FDA SRS | U9JLP7V031 |
| Guide to Pharmacology | 7684 |
CONTENTS